Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Sarah Mcmahon is listed as Senior Vice President, Business Unit Head, Sleep at Jazz Pharmaceuticals, based in Philadelphia, Pennsylvania, United States. AeroLeads shows a matched LinkedIn profile for Sarah Mcmahon.
Sarah Mcmahon previously worked as Vice President, Global Product And Portfolio Strategy at Jazz Pharmaceuticals and Vice President, Global Franchise Lead, Neuroscience, Global Product Strategy at Jazz Pharmaceuticals. Sarah Mcmahon holds Doctor Of Philosophy - Phd from University Of Leeds.
This section adds company-level context without repeating Sarah Mcmahon's masked contact details.
Review company-level records connected to Sarah Mcmahon before choosing the right outreach path.
Impactful leader of people, products, and process with over twenty years biopharma experience working in the UK, USA and Asia. Extensive end-to-end strategic experience with a proven ability to partner across the business to build enduring portfolios, and successfully develop, launch and commercialize differentiated medicines. Highly effective collaborative working in complex matrix organizations. Provide credible and influential leadership to drive decision-making and the performance of global cross-functional teams. Create value through the development and implementation of compelling patient-centric strategies and plans based on a deep understanding of the product and synthesis of market, competitor and customer insight. Drive the business through effective interactions with C-suite executives. Contribute to business transformation by establishing new roles and ways of working, and building, leading and retaining high-performing teams. Expertise includes: Matrix Team Leadership - Strategy to Execution - Product Strategy - Portfolio Management - Product Development - Program Management - Commercial Development - Global Marketing - New Products - Commercial Input to R&D - Launch - Lifecycle Management - Cardiovascular - Diabetes - Oncology - Neuroscience
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Dublin, Ie
Lead the sales and marketing functions, and collaborate across the business to oversee the development of strategic and tactical plans to deliver P&L for the Sleep Business Unit.
Dublin, Ie
Oct 2022-Jul 2024: Global Product Team Lead, Epidiolex, accountable for leading cross-functional matrix team to refine and implement global product strategy, including prioritized strategic growth initiatives, formulation development, geographic expansion, new indication expansion and product maintenance.Nov 2021-Oct 2022: Accountable for Global Franchise Strategy, Disease Area Strategy and Global Molecule Strategy across both the Neuroscience and Oncology portfolios. Lead operating model and process enhancements for the matrix teams. Global Franchise Lead for Neuroscience and line manager of the Global Molecule Leads.
Dublin, Ie
Provide strategic leadership and partner across the business to develop and implement a transformative global neuroscience franchise strategy that addresses unmet patient needs and optimizes value. Build, prioritize and progress an enduring, diversified portfolio consisting of internal assets and targeted external acquisitions. Partner with functional area leaders to identify and build the necessary capabilities to execute the global franchise strategy. Line-manage and develop a team of neuroscience Global Molecule Leads. Contribute to Corporate Strategy and Cross-Franchise initiatives.
Dublin, Ie
Led the cross-functional Global Molecule Team for Defitelio and a Global Technology Team for the proprietary CombiPlex platform to develop and implement global strategies which integrate unmet need, scientific rationale, clinical development, regulatory, CMC and commercial strategy, and optimizes value over the lifecycle.
Cambridge, Cambridgeshire, Gb
Led a team of regional marketing managers to support the promoted brands with Asia Pacific regional sales of $6 billion USD in 2012. Worked collaboratively with local marketing companies and global brand teams to build regional marketing capabilities and identify opportunities to drive brand performance, with a focus on the priority markets and growth brands, Crestor, Nexium, Symbicort, Iressa and Seroquel.
Cambridge, Cambridgeshire, Gb
Successful global commercial leadership of Farxiga / Forxiga (dapagliflozin) through major milestones and investment decisions from the end of phase 2 to simultaneous regulatory filing in US and Europe and preparation for a first-in-class launch in type 2 diabetes. Effective collaboration with partner, Bristol Myers Squibb, R&D and with local marketing companies to develop a compelling, differentiated label and a customer-focused launch brand strategy.
Cambridge, Cambridgeshire, Gb
Led customer, market and competitor insight generation across the portfolio and responsible for commercial input to the Diabetes and Obesity Disease Area Strategy Team. Championed a new approach to provide the “voice of the customer into R&D” to help prioritize the pipeline and create compelling differentiated disease area and emerging brand strategies. Played a pivotal role on the senior capabilities team which secured the major late-stage diabetes deal with Bristol Myers Squibb.
Cambridge, Cambridgeshire, Gb
Global strategic and operational planning for Crestor with sales of $1.3 billion USD in 2005. Including chair of the Commercial Operations Team, leadership of the cross-functional team to develop and implement the innovative GALAXY Program, and responsible for providing global commercial input to the outcomes study strategy.
Cambridge, Cambridgeshire, Gb
Established and championed a new role to provide strategic internal communications support across all therapy areas to manage the timely, consistent global dissemination of product-related news. Member of the Communications Leadership Team to support the development of the overall AstraZeneca communications strategy owned by the senior executive team.
Brentford, Middlesex, Gb
Led cross-functional teams which worked at the medical-marketing interface to develop global communications strategies to ensure successful dissemination of key product messages for a number of emerging brands and established products in oncology and supportive care, including Zofran a leading anti-emetic with sales of $865 million USD in 2000.
Quick answers generated from the profile data available on this page.
Sarah Mcmahon works for Jazz Pharmaceuticals.
Sarah Mcmahon is listed as Senior Vice President, Business Unit Head, Sleep at Jazz Pharmaceuticals.
Sarah Mcmahon is based in Philadelphia, Pennsylvania, United States while working with Jazz Pharmaceuticals.
Sarah Mcmahon has worked for Jazz Pharmaceuticals, Astrazeneca, and Glaxowellcome.
You can use AeroLeads to view verified contact signals for Sarah Mcmahon at Jazz Pharmaceuticals, including work email, phone, and LinkedIn data when available.
Sarah Mcmahon holds Doctor Of Philosophy - Phd from University Of Leeds.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts